These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
85 results:

  • 1. Association of CD8
    Yang J; Ding X; Fang Z; Wu S; Yuan M; Chen R; Xu Q; Gao X; Wu H; Chen L; Zheng X; Jiang J
    BMC Cancer; 2024 Jul; 24(1):869. PubMed ID: 39030523
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated cancers in Patients With Type 2 Diabetes.
    Wang L; Xu R; Kaelber DC; Berger NA
    JAMA Netw Open; 2024 Jul; 7(7):e2421305. PubMed ID: 38967919
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and prognosis in Patients After Radical Resection of colorectal cancer].
    Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
    Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
    Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in colorectal cancer.
    Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
    von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
    Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
    Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
    Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
    Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
    Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes.
    Lun W; Luo C
    BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer.
    Liu XT; Kou ZY; Zhang H; Dong J; Zhang JH; Peng YJ; Ma SM; Liang L; Meng XY; Zhou Y; Yang J
    PeerJ; 2023; 11():e15261. PubMed ID: 37151285
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
    Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Changing trends, clinicopathological characteristics, surgical treatment patterns, and prognosis of schistosomiasis-associated versus non-schistosomiasis-associated colorectal cancer: a large retrospective cohort study of 31 153 cases in Shanghai, China (2001-2021).
    Zheng N; Wang H; Yu Q; Wang C; Bai CG; Pan AF; Jiang J; Lu J; Dai SM; Mei Z; Zhang W; Gao XH
    Int J Surg; 2023 Apr; 109(4):772-784. PubMed ID: 36999800
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Has_circ_0071803 promotes colorectal cancer progression by regulating miR-330-5p/MAPK signaling pathway.
    Huang L; Dou G; Lu J; Chen Z; Wang J
    Histol Histopathol; 2023 Dec; 38(12):1443-1451. PubMed ID: 36856372
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
    Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Construction of a colorectal cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
    Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
    Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The complementary role of lymphovascular invasion and perineural invasion in the TNM staging process of rectal cancer.
    Chen T; Wang M; Cheng X; Wang Y; Jiang Y; Fang X; Xiao H
    Medicine (Baltimore); 2022 Sep; 101(39):e30687. PubMed ID: 36181060
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.